Candriam SCA’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-80,975
Closed -$5.91M – 721
2025
Q3
$5.91M Buy
80,975
+26,481
+49% +$1.94M 0.03% 345
2025
Q2
$4.13M Buy
+54,494
New +$3.86M 0.02% 385
2025
Q1
– Sell
-7,829
Closed -$583K – 664
2024
Q4
$517K Buy
+7,829
New +$548K ﹤0.01% 626

Other funds holding SOLV

Candriam SCA's SOLV Position: Q4 2025 in Review

Candriam SCA sold out of Solventum (SOLV) in Q4 2025, closing a stake of 80,975 shares — an estimated $5.91M sold.

Candriam SCA first reported a position in SOLV in Q4 2024 and held it in 3 quarters. The position peaked at $5.91M in Q3 2025. 942 funds tracked by Wall St. Rank hold SOLV as of Q4 2025.

  • Candriam SCA reported no remaining Solventum position as of Q4 2025 after selling out during the quarter.
  • Candriam SCA sold 80,975 Solventum shares in Q4 2025, an estimated $5.91M.
  • Candriam SCA first reported a position in Solventum in Q4 2024 and held it in 3 quarters.
  • Candriam SCA's Solventum position peaked at $5.91M in Q3 2025.
  • 942 funds tracked by Wall St. Rank held Solventum as of Q4 2025.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.